- MediPharm Labs (MEDIF, Financial) to announce Q1 2025 financial results on May 14, 2025.
- A conference call and webcast will be held at 10:00 a.m. Eastern time on the same day.
- Investors can access the call via North America Toll-Free at (888) 330-2454 or International Toll at +1 (240) 789-2714, Conference ID 4921762.
MediPharm Labs Corp. (MEDIF), a leader in pharmaceutical-grade cannabinoids, will release its first quarter 2025 financial results on Wednesday, May 14, 2025, before the markets open. This announcement will include the company's performance for the period ended March 31, 2025.
Following the release, the company has scheduled a conference call and webcast at 10:00 a.m. Eastern time to provide insights into the financial results and discuss future prospects. Participants are encouraged to dial in approximately 15 minutes before the call starts. For those who miss the live broadcast, a replay will be available on the company's investor relations website approximately one day after the call.
MediPharm Labs is known for its precise cannabinoid products and continues to expand its influence in both domestic and international markets through strategic acquisitions, including the purchase of VIVO Cannabis Inc. in 2023. This expansion has bolstered MediPharm's reach to medical patients across Canada, Australia, and Germany.
Investors and analysts are keenly watching the upcoming financial release and the subsequent discussion, as it provides significant insights into the company's operational strategies and financial health.
